JP2015518837A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518837A5
JP2015518837A5 JP2015512890A JP2015512890A JP2015518837A5 JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5 JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5
Authority
JP
Japan
Prior art keywords
compound
salt
formula
process according
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512890A
Other languages
English (en)
Japanese (ja)
Other versions
JP6214636B2 (ja
JP2015518837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041624 external-priority patent/WO2013173736A1/en
Publication of JP2015518837A publication Critical patent/JP2015518837A/ja
Publication of JP2015518837A5 publication Critical patent/JP2015518837A5/ja
Application granted granted Critical
Publication of JP6214636B2 publication Critical patent/JP6214636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512890A 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス Active JP6214636B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US61/648,421 2012-05-17
US201361785281P 2013-03-14 2013-03-14
US61/785,281 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (3)

Publication Number Publication Date
JP2015518837A JP2015518837A (ja) 2015-07-06
JP2015518837A5 true JP2015518837A5 (https=) 2016-07-07
JP6214636B2 JP6214636B2 (ja) 2017-10-18

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512890A Active JP6214636B2 (ja) 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス

Country Status (18)

Country Link
US (1) US9309204B2 (https=)
EP (1) EP2861583B1 (https=)
JP (1) JP6214636B2 (https=)
KR (1) KR20150020211A (https=)
CN (1) CN104487430B (https=)
AU (1) AU2013262568B2 (https=)
BR (1) BR112014028570A2 (https=)
CA (1) CA2873653A1 (https=)
DK (1) DK2861583T3 (https=)
ES (1) ES2588878T3 (https=)
IL (1) IL235714A0 (https=)
MA (1) MA37649B1 (https=)
MX (1) MX2014013865A (https=)
PL (1) PL2861583T3 (https=)
RU (1) RU2014151017A (https=)
SG (1) SG11201407613RA (https=)
SI (1) SI2861583T1 (https=)
WO (1) WO2013173736A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX350443B (es) 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
HRP20200992T1 (hr) 2012-05-17 2020-10-16 Genentech, Inc. Amorfni oblik pirimidinil-ciklopentanskog spoja koji inhibira akt, te njegovi pripravci i postupci
AU2013262505B2 (en) 2012-05-17 2017-09-21 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
ES2765511T3 (es) 2013-11-15 2020-06-09 Hoffmann La Roche Procesos para la preparación de compuestos de pirimidinilciclopentano
SG11201601813UA (en) * 2013-11-27 2016-04-28 Sunshine Lake Pharma Co Ltd Processes for preparing dihydropyrimidine derivatives and intermediates thereof
ES2749100T3 (es) * 2014-09-26 2020-03-19 Hoffmann La Roche Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina
IL295929A (en) 2020-06-16 2022-10-01 Hoffmann La Roche Process for making hydroxylated cyclopentylpyrimidine compounds
KR102689151B1 (ko) * 2021-09-06 2024-07-29 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09506369A (ja) 1993-12-12 1997-06-24 アグロジーン・リミテッド 菌類感染から植物を保護するための新規方法
AU724216B2 (en) 1997-04-07 2000-09-14 Merck & Co., Inc. A method of treating cancer
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
CA2363169A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
CN1178931C (zh) * 1999-06-03 2004-12-08 帝国脏器制药株式会社 取代吡唑化合物
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
JP4550811B2 (ja) 2003-06-09 2010-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング パピローマウイルスのインヒビター
CA2546754A1 (en) 2003-11-21 2005-06-09 Array Biopharma Inc. Akt protein kinase inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
CN101918373B (zh) * 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
EP2209775A1 (en) 2007-10-09 2010-07-28 UCB Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
NZ586346A (en) * 2008-01-09 2012-02-24 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
AU2009303475B2 (en) * 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
CN102459165B (zh) 2009-04-15 2015-09-02 Abbvie公司 抗病毒化合物
MX2012004780A (es) 2009-10-23 2012-08-23 Lilly Co Eli Inhibidores de akt.
EP2592933B1 (en) 2010-07-16 2017-04-05 Anderson Gaweco Mif inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
AU2013262505B2 (en) 2012-05-17 2017-09-21 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
MX350443B (es) 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
WO2014071194A2 (en) 2012-11-01 2014-05-08 Katz Robert S Methods for treating fibromyalgia
WO2014127350A1 (en) 2013-02-18 2014-08-21 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
WO2014150395A1 (en) 2013-03-15 2014-09-25 Shifa Biomedical Corporation Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Similar Documents

Publication Publication Date Title
JP2015518837A5 (https=)
RU2014151017A (ru) Способ получения гидроксилированных циклопентилпиримидинов
JP2012506425A5 (https=)
JP2011121989A5 (https=)
JP2012140458A5 (https=)
JP2015512868A5 (ja) ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化
JP2014511367A5 (https=)
JP2013147496A5 (ja) 有機金属錯体
JP2009235096A5 (https=)
IL229800A (en) Method of production of bicyclic compound by iminium salt
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
JP2012094862A5 (https=)
WO2014199348A3 (en) Metal doped silicate catalysts for the selective conversion of ethanol to butadiene
BR112018004447A2 (pt) derivado de biarila e medicamento contendo o mesmo
RU2019119584A (ru) Способ получения триазолопиридинового соединения
JP2014520075A5 (https=)
HRP20180948T1 (hr) Postupak za proizvodnju aminokiselinskih spojeva
JP2018009003A5 (https=)
JP2014508714A5 (https=)
JP2016539168A5 (https=)
JP2013241421A5 (https=)
HRP20191632T1 (hr) Kemijski postupak dobivanja spiroindolona i njihovih međuprodukata
AU2012264476A8 (en) Process for the preparation of paliperidone
RU2015118152A (ru) Новое сложноэфирное соединение алициклической дикарбоновой кислоты и способ его изготовления
RU2016112136A (ru) Способ получения 1,1-дибром-1-фторэтана